The paper’s objectives are twofold : to propose an experimental simulation to measure scope economies between pairs of submarkets and to point out the role of submarkets in explaining the concentration level in the pharmaceutical market. We simulate scope economies consistent with the diversification choices of large international companies in the years 1987 and 1997. Our results suggest that: i) the random diversification (that is no scope economies hypothesis) is rejected, and ii) scope economies are significant.
Scope Economies in the Pharmaceutical Sector / M.L. Giorgetti. - In: RIVISTA INTERNAZIONALE DI SCIENZE ECONOMICHE E COMMERCIALI. - ISSN 0035-6751. - 53:3(2006), pp. 373-401. [10.1007/BF03029787]
Scope Economies in the Pharmaceutical Sector
M.L. GiorgettiPrimo
2006
Abstract
The paper’s objectives are twofold : to propose an experimental simulation to measure scope economies between pairs of submarkets and to point out the role of submarkets in explaining the concentration level in the pharmaceutical market. We simulate scope economies consistent with the diversification choices of large international companies in the years 1987 and 1997. Our results suggest that: i) the random diversification (that is no scope economies hypothesis) is rejected, and ii) scope economies are significant.
| File | Dimensione | Formato | |
|---|---|---|---|
|
P59_Giorgetti_settembre_2006_last.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
297.03 kB
Formato
Adobe PDF
|
297.03 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
